ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Exoglycosidases Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-17Z17358
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Exoglycosidases Market Research Report 2024
BUY CHAPTERS

Global Exoglycosidases Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17Z17358
Report
November 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ludger Ltd.
CD BioGlyco
Merck
Promega
Creative Enzymes
Abcam

Exoglycosidases Market

The global Exoglycosidases market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Exoglycosidases are enzymes that catalyze the removal of terminal or external monosaccharide residues from glycan structures. These enzymes play a crucial role in glycobiology research by allowing for the selective modification or trimming of glycan chains on proteins or other biomolecules.
From a downstream perspective, Glycan Sequencing accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Exoglycosidases leading manufacturers including Agilent, Ludger, CD BioGlyco, Merck, Promega, Creative-Enzymes, Abcam, etc., dominate supply; the top five capture approximately % of global revenue, with Agilent leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Exoglycosidases market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Exoglycosidases Market Report

Report Metric Details
Report Name Exoglycosidases Market
Segment by Type
  • β-Glucosidase
  • α-Rhamnosidase
  • Exo-inulinase
  • β-D-Xylosidase
  • β-N-Acetylglucosaminidase
  • Others
Segment by Application
  • Glycan Sequencing
  • Glycoprotein Production
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent, Ludger, CD BioGlyco, Merck, Promega, Creative-Enzymes, Abcam
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Exoglycosidases study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Exoglycosidases Market report?

Ans: The main players in the Exoglycosidases Market are Agilent, Ludger, CD BioGlyco, Merck, Promega, Creative-Enzymes, Abcam

What are the Application segmentation covered in the Exoglycosidases Market report?

Ans: The Applications covered in the Exoglycosidases Market report are Glycan Sequencing, Glycoprotein Production, Others

What are the Type segmentation covered in the Exoglycosidases Market report?

Ans: The Types covered in the Exoglycosidases Market report are β-Glucosidase, α-Rhamnosidase, Exo-inulinase, β-D-Xylosidase, β-N-Acetylglucosaminidase, Others

1 Study Coverage
1.1 Introduction to Exoglycosidases: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Exoglycosidases Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 β-Glucosidase
1.2.3 α-Rhamnosidase
1.2.4 Exo-inulinase
1.2.5 β-D-Xylosidase
1.2.6 β-N-Acetylglucosaminidase
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Exoglycosidases Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Glycan Sequencing
1.3.3 Glycoprotein Production
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Exoglycosidases Revenue Estimates and Forecasts 2020-2031
2.2 Global Exoglycosidases Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Exoglycosidases Sales Estimates and Forecasts 2020-2031
2.4 Global Exoglycosidases Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Exoglycosidases Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Exoglycosidases Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Exoglycosidases Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 β-Glucosidase Market Size by Manufacturers
4.5.2 α-Rhamnosidase Market Size by Manufacturers
4.5.3 Exo-inulinase Market Size by Manufacturers
4.5.4 β-D-Xylosidase Market Size by Manufacturers
4.5.5 β-N-Acetylglucosaminidase Market Size by Manufacturers
4.5.6 Others Market Size by Manufacturers
4.6 Global Exoglycosidases Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Exoglycosidases Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Exoglycosidases Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Exoglycosidases Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Exoglycosidases Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Exoglycosidases Sales and Revenue by Type (2020-2031)
7.4 North America Exoglycosidases Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Exoglycosidases Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Exoglycosidases Sales and Revenue by Type (2020-2031)
8.4 Europe Exoglycosidases Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Exoglycosidases Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Exoglycosidases Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Exoglycosidases Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Exoglycosidases Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Exoglycosidases Sales and Revenue by Type (2020-2031)
10.4 Central and South America Exoglycosidases Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Exoglycosidases Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Exoglycosidases Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Exoglycosidases Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Exoglycosidases Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Agilent
12.1.1 Agilent Corporation Information
12.1.2 Agilent Business Overview
12.1.3 Agilent Exoglycosidases Product Models, Descriptions and Specifications
12.1.4 Agilent Exoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Agilent Exoglycosidases Sales by Product in 2024
12.1.6 Agilent Exoglycosidases Sales by Application in 2024
12.1.7 Agilent Exoglycosidases Sales by Geographic Area in 2024
12.1.8 Agilent Exoglycosidases SWOT Analysis
12.1.9 Agilent Recent Developments
12.2 Ludger
12.2.1 Ludger Corporation Information
12.2.2 Ludger Business Overview
12.2.3 Ludger Exoglycosidases Product Models, Descriptions and Specifications
12.2.4 Ludger Exoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Ludger Exoglycosidases Sales by Product in 2024
12.2.6 Ludger Exoglycosidases Sales by Application in 2024
12.2.7 Ludger Exoglycosidases Sales by Geographic Area in 2024
12.2.8 Ludger Exoglycosidases SWOT Analysis
12.2.9 Ludger Recent Developments
12.3 CD BioGlyco
12.3.1 CD BioGlyco Corporation Information
12.3.2 CD BioGlyco Business Overview
12.3.3 CD BioGlyco Exoglycosidases Product Models, Descriptions and Specifications
12.3.4 CD BioGlyco Exoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 CD BioGlyco Exoglycosidases Sales by Product in 2024
12.3.6 CD BioGlyco Exoglycosidases Sales by Application in 2024
12.3.7 CD BioGlyco Exoglycosidases Sales by Geographic Area in 2024
12.3.8 CD BioGlyco Exoglycosidases SWOT Analysis
12.3.9 CD BioGlyco Recent Developments
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Business Overview
12.4.3 Merck Exoglycosidases Product Models, Descriptions and Specifications
12.4.4 Merck Exoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Merck Exoglycosidases Sales by Product in 2024
12.4.6 Merck Exoglycosidases Sales by Application in 2024
12.4.7 Merck Exoglycosidases Sales by Geographic Area in 2024
12.4.8 Merck Exoglycosidases SWOT Analysis
12.4.9 Merck Recent Developments
12.5 Promega
12.5.1 Promega Corporation Information
12.5.2 Promega Business Overview
12.5.3 Promega Exoglycosidases Product Models, Descriptions and Specifications
12.5.4 Promega Exoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Promega Exoglycosidases Sales by Product in 2024
12.5.6 Promega Exoglycosidases Sales by Application in 2024
12.5.7 Promega Exoglycosidases Sales by Geographic Area in 2024
12.5.8 Promega Exoglycosidases SWOT Analysis
12.5.9 Promega Recent Developments
12.6 Creative-Enzymes
12.6.1 Creative-Enzymes Corporation Information
12.6.2 Creative-Enzymes Business Overview
12.6.3 Creative-Enzymes Exoglycosidases Product Models, Descriptions and Specifications
12.6.4 Creative-Enzymes Exoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Creative-Enzymes Recent Developments
12.7 Abcam
12.7.1 Abcam Corporation Information
12.7.2 Abcam Business Overview
12.7.3 Abcam Exoglycosidases Product Models, Descriptions and Specifications
12.7.4 Abcam Exoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Abcam Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Exoglycosidases Industry Chain
13.2 Exoglycosidases Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Exoglycosidases Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Exoglycosidases Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Exoglycosidases Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Exoglycosidases Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Ludger Ltd.
CD BioGlyco
Merck
Promega
Creative Enzymes
Abcam
List of Tables
 Table 1. Global Exoglycosidases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Exoglycosidases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Exoglycosidases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Exoglycosidases Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Exoglycosidases Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Exoglycosidases Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
 Table 7. Global Exoglycosidases Sales by Region (2020-2025) & (kg)
 Table 8. Global Exoglycosidases Sales by Region (2026-2031) & (kg)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Exoglycosidases Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
 Table 11. Global Exoglycosidases Production by Region (2020-2025) & (kg)
 Table 12. Global Exoglycosidases Production by Region (2026-2031) & (kg)
 Table 13. Global Exoglycosidases Sales by Manufacturers (2020-2025) & (kg)
 Table 14. Global Exoglycosidases Sales Share by Manufacturers (2020-2025)
 Table 15. Global Exoglycosidases Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Exoglycosidases Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Exoglycosidases by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exoglycosidases as of 2024)
 Table 19. Global Exoglycosidases Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Exoglycosidases Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
 Table 21. Key Manufacturers Exoglycosidases Manufacturing Base and Headquarters
 Table 22. Global Exoglycosidases Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Exoglycosidases Sales by Type (2020-2025) & (kg)
 Table 26. Global Exoglycosidases Sales by Type (2026-2031) & (kg)
 Table 27. Global Exoglycosidases Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Exoglycosidases Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Exoglycosidases ASP by Type (2020-2031) & (US$/g)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Exoglycosidases Sales by Application (2020-2025) & (kg)
 Table 32. Global Exoglycosidases Sales by Application (2026-2031) & (kg)
 Table 33. Exoglycosidases High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Exoglycosidases Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Exoglycosidases Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Exoglycosidases ASP by Application (2020-2031) & (US$/g)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Exoglycosidases Growth Accelerators and Market Barriers
 Table 40. North America Exoglycosidases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Exoglycosidases Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Exoglycosidases Growth Accelerators and Market Barriers
 Table 43. Europe Exoglycosidases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Exoglycosidases Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Exoglycosidases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Exoglycosidases Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Exoglycosidases Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Exoglycosidases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Exoglycosidases Investment Opportunities and Key Challenges
 Table 50. Central and South America Exoglycosidases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Exoglycosidases Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Exoglycosidases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Agilent Corporation Information
 Table 54. Agilent Description and Major Businesses
 Table 55. Agilent Product Models, Descriptions and Specifications
 Table 56. Agilent Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 57. Agilent Sales Value Proportion by Product in 2024
 Table 58. Agilent Sales Value Proportion by Application in 2024
 Table 59. Agilent Sales Value Proportion by Geographic Area in 2024
 Table 60. Agilent Exoglycosidases SWOT Analysis
 Table 61. Agilent Recent Developments
 Table 62. Ludger Corporation Information
 Table 63. Ludger Description and Major Businesses
 Table 64. Ludger Product Models, Descriptions and Specifications
 Table 65. Ludger Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 66. Ludger Sales Value Proportion by Product in 2024
 Table 67. Ludger Sales Value Proportion by Application in 2024
 Table 68. Ludger Sales Value Proportion by Geographic Area in 2024
 Table 69. Ludger Exoglycosidases SWOT Analysis
 Table 70. Ludger Recent Developments
 Table 71. CD BioGlyco Corporation Information
 Table 72. CD BioGlyco Description and Major Businesses
 Table 73. CD BioGlyco Product Models, Descriptions and Specifications
 Table 74. CD BioGlyco Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 75. CD BioGlyco Sales Value Proportion by Product in 2024
 Table 76. CD BioGlyco Sales Value Proportion by Application in 2024
 Table 77. CD BioGlyco Sales Value Proportion by Geographic Area in 2024
 Table 78. CD BioGlyco Exoglycosidases SWOT Analysis
 Table 79. CD BioGlyco Recent Developments
 Table 80. Merck Corporation Information
 Table 81. Merck Description and Major Businesses
 Table 82. Merck Product Models, Descriptions and Specifications
 Table 83. Merck Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 84. Merck Sales Value Proportion by Product in 2024
 Table 85. Merck Sales Value Proportion by Application in 2024
 Table 86. Merck Sales Value Proportion by Geographic Area in 2024
 Table 87. Merck Exoglycosidases SWOT Analysis
 Table 88. Merck Recent Developments
 Table 89. Promega Corporation Information
 Table 90. Promega Description and Major Businesses
 Table 91. Promega Product Models, Descriptions and Specifications
 Table 92. Promega Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Promega Sales Value Proportion by Product in 2024
 Table 94. Promega Sales Value Proportion by Application in 2024
 Table 95. Promega Sales Value Proportion by Geographic Area in 2024
 Table 96. Promega Exoglycosidases SWOT Analysis
 Table 97. Promega Recent Developments
 Table 98. Creative-Enzymes Corporation Information
 Table 99. Creative-Enzymes Description and Major Businesses
 Table 100. Creative-Enzymes Product Models, Descriptions and Specifications
 Table 101. Creative-Enzymes Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 102. Creative-Enzymes Recent Developments
 Table 103. Abcam Corporation Information
 Table 104. Abcam Description and Major Businesses
 Table 105. Abcam Product Models, Descriptions and Specifications
 Table 106. Abcam Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 107. Abcam Recent Developments
 Table 108. Key Raw Materials Distribution
 Table 109. Raw Materials Key Suppliers
 Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 111. Milestones in Production Technology Evolution
 Table 112. Distributors List
 Table 113. Market Trends and Market Evolution
 Table 114. Market Drivers and Opportunities
 Table 115. Market Challenges, Risks, and Restraints
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. Exoglycosidases Product Picture
 Figure 2. Global Exoglycosidases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. β-Glucosidase Product Picture
 Figure 4. α-Rhamnosidase Product Picture
 Figure 5. Exo-inulinase Product Picture
 Figure 6. β-D-Xylosidase Product Picture
 Figure 7. β-N-Acetylglucosaminidase Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Exoglycosidases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 10. Glycan Sequencing
 Figure 11. Glycoprotein Production
 Figure 12. Others
 Figure 13. Exoglycosidases Report Years Considered
 Figure 14. Global Exoglycosidases Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Exoglycosidases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Exoglycosidases Revenue Market Share by Region (2020-2031)
 Figure 18. Global Exoglycosidases Sales (2020-2031) & (kg)
 Figure 19. Global Exoglycosidases Sales (CAGR) by Region (2020-2031) (kg)
 Figure 20. Global Exoglycosidases Sales Market Share by Region (2020-2031)
 Figure 21. Global Exoglycosidases Capacity, Production and Utilization (2020-2031) & (kg)
 Figure 22. Global Exoglycosidases Production Trend by Region (2020-2031) (kg)
 Figure 23. Global Exoglycosidases Production Market Share by Region (2020-2031)
 Figure 24. Production Capacity Enablers & Constraints
 Figure 25. Exoglycosidases Production Growth Rate in North America (2020-2031) & (kg)
 Figure 26. Exoglycosidases Production Growth Rate in Europe (2020-2031) & (kg)
 Figure 27. Exoglycosidases Production Growth Rate in China (2020-2031) & (kg)
 Figure 28. Exoglycosidases Production Growth Rate in Japan (2020-2031) & (kg)
 Figure 29. Top 5 and Top 10 Manufacturers Exoglycosidases Sales Volume Market Share in 2024
 Figure 30. Global Exoglycosidases Revenue Market Share Ranking (2024)
 Figure 31. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 32. β-Glucosidase Revenue Market Share by Manufacturer in 2024
 Figure 33. α-Rhamnosidase Revenue Market Share by Manufacturer in 2024
 Figure 34. Exo-inulinase Revenue Market Share by Manufacturer in 2024
 Figure 35. β-D-Xylosidase Revenue Market Share by Manufacturer in 2024
 Figure 36. β-N-Acetylglucosaminidase Revenue Market Share by Manufacturer in 2024
 Figure 37. Others Revenue Market Share by Manufacturer in 2024
 Figure 38. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 39. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 40. Global Exoglycosidases Sales Market Share by Type (2020-2031)
 Figure 41. Global Exoglycosidases Revenue Market Share by Type (2020-2031)
 Figure 42. Global Exoglycosidases Sales Market Share by Application (2020-2031)
 Figure 43. Global Exoglycosidases Revenue Market Share by Application (2020-2031)
 Figure 44. North America Exoglycosidases Sales YoY (2020-2031) & (kg)
 Figure 45. North America Exoglycosidases Revenue YoY (2020-2031) & (US$ Million)
 Figure 46. North America Top 5 Manufacturers Exoglycosidases Sales Revenue (US$ Million) in 2024
 Figure 47. North America Exoglycosidases Sales Volume (kg) by Type (2020- 2031)
 Figure 48. North America Exoglycosidases Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 49. North America Exoglycosidases Sales Volume (kg) by Application (2020-2031)
 Figure 50. North America Exoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 51. US Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 52. Canada Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 53. Mexico Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 54. Europe Exoglycosidases Sales YoY (2020-2031) & (kg)
 Figure 55. Europe Exoglycosidases Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Europe Top 5 Manufacturers Exoglycosidases Sales Revenue (US$ Million) in 2024
 Figure 57. Europe Exoglycosidases Sales Volume (kg) by Type (2020-2031)
 Figure 58. Europe Exoglycosidases Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Europe Exoglycosidases Sales Volume (kg) by Application (2020-2031)
 Figure 60. Europe Exoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 61. Germany Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 62. France Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 63. U.K. Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 64. Italy Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 65. Russia Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 66. Asia-Pacific Exoglycosidases Sales YoY (2020-2031) & (kg)
 Figure 67. Asia-Pacific Exoglycosidases Revenue YoY (2020-2031) & (US$ Million)
 Figure 68. Asia-Pacific Top 8 Manufacturers Exoglycosidases Sales Revenue (US$ Million) in 2024
 Figure 69. Asia-Pacific Exoglycosidases Sales Volume (kg) by Type (2020- 2031)
 Figure 70. Asia-Pacific Exoglycosidases Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 71. Asia-Pacific Exoglycosidases Sales Volume (kg) by Application (2020-2031)
 Figure 72. Asia-Pacific Exoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 73. Indonesia Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 74. Japan Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 75. South Korea Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 76. China Taiwan Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 77. India Exoglycosidases Revenue (2020-2031) & (US$ Million)
 Figure 78. Central and South America Exoglycosidases Sales YoY (2020-2031) & (kg)
 Figure 79. Central and South America Exoglycosidases Revenue YoY (2020-2031) & (US$ Million)
 Figure 80. Central and South America Top 5 Manufacturers Exoglycosidases Sales Revenue (US$ Million) in 2024
 Figure 81. Central and South America Exoglycosidases Sales Volume (kg) by Type (2021-2031)
 Figure 82. Central and South America Exoglycosidases Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 83. Central and South America Exoglycosidases Sales Volume (kg) by Application (2020-2031)
 Figure 84. Central and South America Exoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 85. Brazil Exoglycosidases Revenue (2020-2025) & (US$ Million)
 Figure 86. Argentina Exoglycosidases Revenue (2020-2025) & (US$ Million)
 Figure 87. Middle East, and Africa Exoglycosidases Sales YoY (2020-2031) & (kg)
 Figure 88. Middle East and Africa Exoglycosidases Revenue YoY (2020-2031) & (US$ Million)
 Figure 89. Middle East and Africa Top 5 Manufacturers Exoglycosidases Sales Revenue (US$ Million) in 2024
 Figure 90. Middle East and Africa Exoglycosidases Sales Volume (kg) by Type (2021-2031)
 Figure 91. South America Exoglycosidases Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 92. Middle East and Africa Exoglycosidases Sales Volume (kg) by Application (2020-2031)
 Figure 93. Middle East and Africa Exoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 94. GCC Countries Exoglycosidases Revenue (2020-2025) & (US$ Million)
 Figure 95. Turkey Exoglycosidases Revenue (2020-2025) & (US$ Million)
 Figure 96. Egypt Exoglycosidases Revenue (2020-2025) & (US$ Million)
 Figure 97. South Africa Exoglycosidases Revenue (2020-2025) & (US$ Million)
 Figure 98. Exoglycosidases Industry Chain Mapping
 Figure 99. Regional Exoglycosidases Manufacturing Base Distribution (%)
 Figure 100. Exoglycosidases Production Process
 Figure 101. Regional Exoglycosidases Production Cost Structure
 Figure 102. Channels of Distribution (Direct Vs Distribution)
 Figure 103. Bottom-up and Top-down Approaches for This Report
 Figure 104. Data Triangulation
 Figure 105. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Endoglycosidases Market Research Report 2024
Glycosidases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glycobiology Enzymes Market Research Report 2024
Global Amyloglucosidase Market Research Report 2025
Global Galactosidase Market Insights Forecast to 2030
Global N glycanase Market Insights Forecast to 2030
Beta galactosidase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pullulanase Market Insights Forecast to 2030
Global Carbohydrases Industrial Enzyme Market Research Report 2024
Global Alpha Galactosidase Market Insights Forecast to 2030
Global Carbohydrases Market Research Report 2024
Global Glucoamylase for Food Market Research Report 2024
Global Glycobiology Glycomics Market Insights Forecast to 2030
Global Carbohydrate Active Enzyme Market Research Report 2024
Global Feed Glucanase Market Insights Forecast to 2030
Global Hyaluronidase Market Research Report 2024
Hemicellulase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Feed Galactosidase Market Insights Forecast to 2030
Global Starch Processing Enzymes Market Research Report 2024
Global α Glucosidase Assay Kit Market Research Report 2025

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions